Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

HTA unit of Lombardy region calls for public input

The HTA unit of the Lombardy region opens the possibility for the public to comment on the health technologies which are in the assessment phase. Those are the technologies about which MTRC already wrote in December 2019.

The call is open until February 28, 2020.

During the same period, the draft HTA reports will be reviewed by scientific experts. From March, the revised versions of the technical HTA reports and any contributions collected through the public consultations will be used by the HTA Regional Commission for the development of appraisal judgments, a phase that includes the production of recommendations regarding the appropriate use of technologies evaluated.

See the whole news in Italian here.

Visit our online school if you want to learn EU Health technology assessments for medical technologies.

This is a syndicated report on HTA landscape and all published non-drug HTAs in Europe in 2018, including medical devices and procedures, in-vitro diagnostic tests and e-health solutions.

The HTA report covers 12 EU countries (Austria, Belgium, Denmark, England, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, Switzerland) and EUnetHTA.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.